Patents by Inventor John Gerard Steele

John Gerard Steele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6503958
    Abstract: The present invention relates to porous polymers incorporating dihydroperfluoroalkyl acrylates and methacrylates and the like and their production. The invention also relates to the use of polymers derived from dihydroperfluoroalkyl acrylates and methacrylates and like compounds, in both porous and non-porous forms, as substrates for the attachment and growth of mammalian cells and tissue. The invention also relates to the use of polymers derived from dihydroperfluoroalkyl acrylates and methacrylates as components of medical devices and prostheses, including implanted devices.
    Type: Grant
    Filed: August 14, 2001
    Date of Patent: January 7, 2003
    Assignee: Novartis AG
    Inventors: Timothy Charles Hughes, Gordon Francis Meijs, Hassan Chaouk, John Gerard Steele, Graham Johnson
  • Patent number: 6454800
    Abstract: A corneal onlay or corneal implant is disclosed which is to be placed within or onto the surface of the cornea, being a biocompatible, optically transparent, synthetic and biostable polymeric material, said material comprising a surface that supports the attachment and growth of tissue cells, and where the exterior surface of the implant onto which epithelial tissue is to be attracted and to become attached, or in the case of a corneal onlay the anterior surface of the onlay, has a topography comprising a plurality of surface indentations.
    Type: Grant
    Filed: February 12, 2001
    Date of Patent: September 24, 2002
    Assignee: Novartis AG
    Inventors: Beatrice Ann Dalton, John Gerard Steele, Margaret Diana Macrea Evans, Janet Helen Fitton, Graham Johnson, Ilene Kay Gipson
  • Publication number: 20020103538
    Abstract: The present invention relates to porous polymers incorporating dihydroperfluoroalkyl acrylates and methacrylates and the like and their production. The invention also relates to the use of polymers derived from dihydroperfluoroalkyl acrylates and methacrylates and like compounds, in both porous and non-porous forms, as substrates for the attachment and growth of mammalian cells and tissue. The invention also relates to the use of polymers derived from dihydroperfluoroalkyl acrylates and methacrylates as components of medical devices and prostheses, including implanted devices.
    Type: Application
    Filed: August 14, 2001
    Publication date: August 1, 2002
    Inventors: Timothy Charles Hughes, Gordon Francis Meijs, Hassan Chaouk, John Gerard Steele, Graham Johnson
  • Publication number: 20010047203
    Abstract: A corneal onlay or corneal implant is disclosed which is to be placed within or onto the surface of the cornea, being a biocompatible, optically transparent, synthetic and biostable polymeric material, said material comprising a surface that supports the attachment and growth of tissue cells, and where the exterior surface of the implant onto which epithelial tissue is to be attracted and to become attached, or in the case of a corneal onlay the anterior surface of the onlay, has a topography comprising a plurality of surface indentations.
    Type: Application
    Filed: February 12, 2001
    Publication date: November 29, 2001
    Inventors: Beatrice Ann Dalton, John Gerard Steele, Margaret Diana Macrea Evans, Janet Helen Fitton, Graham Johnson, Ilene Kay Gipson
  • Patent number: 5994133
    Abstract: Cell growth substrate polymers are described which comprise a macromonomer of the formula (I): Q-(PFPE-L).sub.n-1 -PFPE-Q, wherein n is at least 1.0; each PFPE may be the same or different and is a perfluorinated polyether of the formula (II): --OCH.sub.2 CF.sub.2 O (CF.sub.2 CF.sub.2 O).sub.x (CF.sub.2 O).sub.y CF.sub.2 CH.sub.2 O--, wherein the CF.sub.2 CF.sub.2 O and CF.sub.2 O units may be randomly distributed or distributed as blocks throughout the chain and wherein x and y may be the same or different such that the molecular weight of the perfluoropolyether is in the range of from 242 to 4000, L is a difunctional linking group; and Q at each end of the macromonomer is the same or different and is a polymerizable group. The cell growth substrate polymers may be used in the production of comeal implants.
    Type: Grant
    Filed: January 6, 1998
    Date of Patent: November 30, 1999
    Assignees: Novartis AG, Commonwealth Scientific and Industrial Research Organisation
    Inventors: Gordon Francis Meijs, Bronwyn Glenice Laycock, Madeleine Clare Griffiths, Edith Cheong, John Gerard Steele, Graham Johnson
  • Patent number: 5973089
    Abstract: Macromonomers of the formula I are described:Q-B(L-B).sub.n T (I)wherein n is at least 1.0;Q is a polymerizable group;B may be the same or different and is a difunctional block of molecular weight in the range of from 100 to 4000 and wherein at least one B is a perfluorinated polyether of formula II;--OCH.sub.2 CF.sub.2 O(CF.sub.2 CF.sub.2 O).sub.x (CF.sub.2 O).sub.y CF.sub.2 CH.sub.2 O-- (II)wherein the CF.sub.2 CF.sub.2 O and CF.sub.2 O units may be randomly distributed or distributed as blocks throughout the chain and wherein x and y may be the same or different such that the molecular weight of the perfluorinated polyether is in the range of from 242 to 4,000;L is a difunctional linking group; andT is a terminal group.These macromonomers may be used in the production of contact lenses, corneal implants, cell growth substrate or medical implant.
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: October 26, 1999
    Assignees: Novartis AG, Commonwealth Scientific & Industrial Research Organisation
    Inventors: Gordon Francis Meijs, Bronwyn Glenice Laycock, John Gerard Steele, Graham Johnson
  • Patent number: 5713957
    Abstract: Corneal onlays for use in surgical implantation into or onto the cornea of a mammal are described. The corneal onlays according to the invention have an optical axis region with optical characteristics which provide visual acuity therethrough and are comprised of a non-biodegradable non-hydrogel ocularly biocompatible material, characterized in that the onlay has a porosity sufficient to allow passage therethrough of tissue fluid components having a molecular fluid weight greater than 10,000 daltons so as to provide for a flux of tissue fluid between cells anterior of the implanted onlay and cells posterior thereof. The porosity of the optical axis region is such that it allows the flux of tissue fluid components whilst excluding ingrowth of ocular tissue. The onlay is further characterized by being adapted for epithelial recolonization.
    Type: Grant
    Filed: May 16, 1996
    Date of Patent: February 3, 1998
    Assignees: CIBA Vision Corporation, The Commonwealth of Australia Commonwealth Scientific and Industrial Research Organization
    Inventors: John Gerard Steele, Brien A. Holden, Deborah Sweeney, Dan O'Leary, Klaus Schindhelm, Antti Vannas, Graham Johnson